Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
80
Stocks News & Analysis
stocks
Signs of a turnaround for undervalued ASX share
stocks
Australia has the highest dividend yields in the world, so why the endless chase for even higher yields?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,825.10 | 20.90 | 0.24% |
CAC 40 | 8,178.54 | 14.43 | 0.18% |
DAX 40 | 22,513.42 | 98.60 | -0.44% |
Dow JONES (US) | 44,546.08 | 165.35 | -0.37% |
FTSE 100 | 8,732.46 | 32.26 | -0.37% |
HKSE | 22,620.33 | 805.96 | 3.69% |
NASDAQ | 20,026.77 | 81.13 | 0.41% |
Nikkei 225 | 39,149.43 | 312.04 | -0.79% |
NZX 50 Index | 12,989.18 | 83.20 | 0.64% |
S&P 500 | 6,114.63 | 0.44 | -0.01% |
S&P/ASX 200 | 8,555.80 | 15.80 | 0.19% |
SSE Composite Index | 3,346.72 | 14.24 | 0.43% |